We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
–
AUM
$137M
AUM Growth
+$8.91M
Cap. Flow
+$5.42M
Cap. Flow %
3.95%
Top 10 Hldgs %
25.75%
Holding
1,127
New
41
Increased
160
Reduced
183
Closed
74

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$2.38M
2
BEAT
BioTelemetry, Inc.
BEAT
+$1.32M
3
RPM icon
RPM International
RPM
+$798K
4
DIS icon
Walt Disney
DIS
+$758K
5
COST icon
Costco
COST
+$641K

Top Sells

Rank Stock Value
1
IRBT
iRobot
IRBT
+$1.7M
2
MDSO
Medidata Solutions, Inc.
MDSO
+$958K
3
MSFT icon
Microsoft
MSFT
+$206K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$129K
5
AAPL icon
Apple
AAPL
+$111K

Sector Composition

Rank Sector Weight
1 Technology 27.32%
2 Healthcare 15.28%
3 Financials 10.67%
4 Consumer Staples 7.75%
5 Consumer Discretionary 5.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBDO icon
876
Banco Bradesco
BBDO
$33.8B
$1K ﹤0.01%
119
-6
-5% -$39
BC icon
877
Brunswick
BC
$5.2B
$1K ﹤0.01%
24
– –
BFH icon
878
Bread Financial
BFH
$4.07B
$1K ﹤0.01%
5
– –
BHF icon
879
Brighthouse Financial
BHF
$3.62B
$1K ﹤0.01%
23
– –
BBT
880
Beacon Financial Corp
BBT
$2.53B
$1K ﹤0.01%
20
– –
BMRN icon
881
BioMarin Pharmaceuticals
BMRN
$11.4B
$1K ﹤0.01%
16
– –
CADE
882
DELISTED
Cadence Bank
CADE
$1K ﹤0.01%
32
– –
CHRW icon
883
C.H. Robinson
CHRW
$22.6B
$1K ﹤0.01%
+16
New +$1.35K
CHX
884
DELISTED
ChampionX
CHX
$1K ﹤0.01%
40
– –
CLB icon
885
Core Laboratories
CLB
$557M
$1K ﹤0.01%
11
– –
CMPR icon
886
Cimpress
CMPR
$2.36B
$1K ﹤0.01%
9
– –
CNQ icon
887
Canadian Natural Resources
CNQ
$98.5B
$1K ﹤0.01%
108
-86
-44% -$1.18K
VISN
888
Vistance Networks Inc
VISN
$2.68B
$1K ﹤0.01%
58
– –
COR icon
889
Cencora
COR
$60.2B
$1K ﹤0.01%
17
– –
CPF icon
890
Central Pacific Financial
CPF
$1.01B
$1K ﹤0.01%
42
– –
CSW
891
CSW Industrials
CSW
$4.8B
$1K ﹤0.01%
+21
New +$1.31K
CX icon
892
Cemex
CX
$17.7B
$1K ﹤0.01%
196
– –
DOX icon
893
Amdocs
DOX
$5.51B
$1K ﹤0.01%
22
– –
DSGX icon
894
Descartes Systems
DSGX
$5.77B
$1K ﹤0.01%
+24
New +$934
DXC icon
895
DXC Technology
DXC
$1.57B
$1K ﹤0.01%
25
-275
-92% -$15.9K
EHC icon
896
Encompass Health
EHC
$11.4B
$1K ﹤0.01%
19
– –
ELME
897
Elme Communities
ELME
$132M
$1K ﹤0.01%
51
– –
FCN icon
898
FTI Consulting
FCN
$4.81B
$1K ﹤0.01%
15
– –
FIBK icon
899
First Interstate BancSystem
FIBK
$3.66B
$1K ﹤0.01%
20
– –
GLDD
900
DELISTED
Great Lakes Dredge & Dock
GLDD
$1K ﹤0.01%
114
– –
34 35
36
37 38

Similar funds

SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return
RHP
Royal Harbor Partners Houston, Texas $295M AUM 14.06% 1-Year Est. Return
MSWM
Master's Wealth Management Lancaster, Pennsylvania $295M AUM 15.96% 1-Year Est. Return
RLIM
Red Lighthouse Investment Management New York $296M AUM 22.04% 1-Year Est. Return
JCM
Jacobsen Capital Management Salt Lake City, Utah $296M AUM 24.47% 1-Year Est. Return
CA
Claar Advisors New York $295M AUM 12.26% 1-Year Est. Return
KNFPWM
Keeler & Nadler Financial Planning & Wealth Management Dublin, Ohio $295M AUM 18.48% 1-Year Est. Return
NRC
New Republic Capital Charlotte, North Carolina $297M AUM 24.5% 1-Year Est. Return

Front Row Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Front Row Advisors held 1,127 positions worth $137M, up 6.9% from $128M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Front Row Advisors deployed $5.42M of net new capital in Q2 2019, opening 41 new positions and adding to 160 existing holdings. Its largest new stake was BioTelemetry, Inc.: 25,089 shares worth $1.21M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Microsoft, an estimated $206K trimmed.

  • Front Row Advisors's largest Q2 2019 buy was BioTelemetry, Inc.: 25,089 shares worth $1.21M.
  • Front Row Advisors added most to Medtronic in Q2 2019, an estimated $2.38M increase.
  • Front Row Advisors's biggest Q2 2019 reduction was Microsoft, cutting an estimated $206K.
  • Front Row Advisors fully exited iRobot in Q2 2019, selling an estimated $1.7M.
  • Front Row Advisors's ten largest holdings make up 26% of its $137M portfolio in Q2 2019.
  • Front Row Advisors opened 41 new positions and closed 74 in Q2 2019.
  • Front Row Advisors's portfolio value rose 6.9% quarter-over-quarter to $137M.

Based on Front Row Advisors's 13F filing for Q2 2019, filed 27 Aug 2019.